FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2277889101> ?p ?o ?g. }

• W2277889101 endingPage "963" @default.
• W2277889101 startingPage "945" @default.
• W2277889101 abstract "Within the past decade several novel targets have been indicated as key players in Alzheimer-type dementia and associated conditions, including a frightening memory loss as well as severe cognitive impairments. These proteins are deeply implicated in crucial cell processes, e.g., autophagy, growth and progression, apoptosis, and metabolic equilibrium. Since recently, 5-HT6R has been considered as one of the most prominent biological targets in AD drug therapy. Therefore, we investigated the potential procognitive and neuroprotective effects of our novel selective 5-HT6R antagonist, AVN-211. During an extensive preclinical evaluation the lead compound demonstrated a relatively high therapeutic potential and improved selectivity toward 5-HT6R as compared to reference drug candidates. It was thoroughly examined in different in vivo behavioral models directly related to AD and showed evident improvements in cognition and learning. In many cases, the observed effect was considerably greater than that determined for the reported drugs and drug candidates, including memantine, SB-742457, and Lu AE58054, evaluated under the same conditions. In addition, AVN-211 showed a similar or better anxiolytic efficacy than fenobam, rufinamide, lorazepam, and buspirone in an elevated plus-maze model, elevated platform, and open field tests. The compound demonstrated low toxicity and no side effects in vivo, an appropriate pharmacokinetic profile, and stability. In conclusion, AVN-211 significantly delayed or partially halted the progressive decline in memory function associated with AD, which makes it an interesting drug candidate for the treatment of neurodegenerative and psychiatric disorders. Advanced clinical trials are currently under active discussion and in high priority." @default.
• W2277889101 created "2016-06-24" @default.
• W2277889101 creator A5033183874 @default.
• W2277889101 creator A5050327613 @default.
• W2277889101 creator A5084379384 @default.
• W2277889101 date "2016-02-26" @default.
• W2277889101 modified "2023-10-16" @default.
• W2277889101 title "AVN-211, Novel and Highly Selective 5-HT₆ Receptor Small Molecule Antagonist, for the Treatment of Alzheimer’s Disease" @default.
• W2277889101 cites W1464665613 @default.
• W2277889101 cites W1494210462 @default.
• W2277889101 cites W1507970994 @default.
• W2277889101 cites W1552020245 @default.
• W2277889101 cites W1575247928 @default.
• W2277889101 cites W1840395037 @default.
• W2277889101 cites W187210528 @default.
• W2277889101 cites W1894699684 @default.
• W2277889101 cites W1918769578 @default.
• W2277889101 cites W1964888279 @default.
• W2277889101 cites W1965718249 @default.
• W2277889101 cites W1972788353 @default.
• W2277889101 cites W1992687049 @default.
• W2277889101 cites W1998299683 @default.
• W2277889101 cites W2000620451 @default.
• W2277889101 cites W2008145156 @default.
• W2277889101 cites W2009023836 @default.
• W2277889101 cites W2009234753 @default.
• W2277889101 cites W2011284760 @default.
• W2277889101 cites W2012070728 @default.
• W2277889101 cites W2013095956 @default.
• W2277889101 cites W2017362427 @default.
• W2277889101 cites W2020193674 @default.
• W2277889101 cites W2023235142 @default.
• W2277889101 cites W2023363102 @default.
• W2277889101 cites W2035514330 @default.
• W2277889101 cites W2036024955 @default.
• W2277889101 cites W2037766848 @default.
• W2277889101 cites W2039294854 @default.
• W2277889101 cites W2041573170 @default.
• W2277889101 cites W2048479010 @default.
• W2277889101 cites W2066745998 @default.
• W2277889101 cites W2069849212 @default.
• W2277889101 cites W2073094854 @default.
• W2277889101 cites W2076144045 @default.
• W2277889101 cites W2081662882 @default.
• W2277889101 cites W2083820216 @default.
• W2277889101 cites W2085050037 @default.
• W2277889101 cites W2090362174 @default.
• W2277889101 cites W2092984538 @default.
• W2277889101 cites W2117877379 @default.
• W2277889101 cites W2118559415 @default.
• W2277889101 cites W2118671543 @default.
• W2277889101 cites W2119059500 @default.
• W2277889101 cites W2120435825 @default.
• W2277889101 cites W2121476689 @default.
• W2277889101 cites W2123262275 @default.
• W2277889101 cites W2124879385 @default.
• W2277889101 cites W2125808190 @default.
• W2277889101 cites W2127948169 @default.
• W2277889101 cites W2129668980 @default.
• W2277889101 cites W2131698145 @default.
• W2277889101 cites W2132876172 @default.
• W2277889101 cites W2151170617 @default.
• W2277889101 cites W2157968215 @default.
• W2277889101 cites W2167567290 @default.
• W2277889101 cites W2312413250 @default.
• W2277889101 cites W2319265080 @default.
• W2277889101 cites W2326304121 @default.
• W2277889101 cites W2399228961 @default.
• W2277889101 cites W2412985605 @default.
• W2277889101 cites W2745524785 @default.
• W2277889101 cites W3190569098 @default.
• W2277889101 cites W32083764 @default.
• W2277889101 cites W4241804791 @default.
• W2277889101 cites W3142350394 @default.
• W2277889101 doi "https://doi.org/10.1021/acs.molpharmaceut.5b00830" @default.
• W2277889101 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26886442" @default.
• W2277889101 hasPublicationYear "2016" @default.
• W2277889101 type Work @default.
• W2277889101 sameAs 2277889101 @default.
• W2277889101 citedByCount "24" @default.
• W2277889101 countsByYear W22778891012016 @default.
• W2277889101 countsByYear W22778891012017 @default.
• W2277889101 countsByYear W22778891012018 @default.
• W2277889101 countsByYear W22778891012019 @default.
• W2277889101 countsByYear W22778891012020 @default.
• W2277889101 countsByYear W22778891012021 @default.
• W2277889101 countsByYear W22778891012022 @default.
• W2277889101 countsByYear W22778891012023 @default.
• W2277889101 crossrefType "journal-article" @default.
• W2277889101 hasAuthorship W2277889101A5033183874 @default.
• W2277889101 hasAuthorship W2277889101A5050327613 @default.
• W2277889101 hasAuthorship W2277889101A5084379384 @default.
• W2277889101 hasConcept C118552586 @default.
• W2277889101 hasConcept C126322002 @default.
• W2277889101 hasConcept C150903083 @default.
• W2277889101 hasConcept C15744967 @default.
• W2277889101 hasConcept C169760540 @default.
• W2277889101 hasConcept C170493617 @default.

• next